ARANTZA
MENDIZABAL ABAD
Investigador/a en el periodo 2016-2020
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadoras/es de Hospital de Cruces (3)
2024
-
Response, complications and risk of leukemic transformation of phosphorus-32 treatment in Philadelphia-negative chronic myeloproliferative syndromes
Revista Espanola de Medicina Nuclear e Imagen Molecular
2022
-
Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75-year-olds newly diagnosed with multiple myeloma
European Journal of Haematology
2021
-
Faggot cells in therapy-related acute myeloid leukemia with inv(16)
Clinical Case Reports, Vol. 9, Núm. 1, pp. 572-573